HSD17B10
HSD17B10 (hydroxysteroid 17-beta dehydrogenase 10) is a mitochondrial short-chain dehydrogenase/reductase that also serves as a subunit of mitochondrial ribonuclease P. It is also known as 3-hydroxyacyl-CoA dehydrogenase type II, ERAB, ABAD, 17b-HSD10, HADH2, MHBD, SDR5C1 and MRPP2. Browse Assay Genie's current range of HSD17B10 research reagents below, or read on for the biology behind the target.
HSD17B10 is a multifunctional mitochondrial protein. As a dehydrogenase, it catalyses the oxidation of a wide variety of fatty acids and steroids. It also moonlights as a component of mitochondrial ribonuclease P, a complex that cleaves tRNA molecules at their 5'-ends. Together with TRMT10C/MRPP1 it forms the MRPP1-MRPP2 subcomplex, which acts independently of ribonuclease P activity. This subcomplex catalyses the formation of N(1)-methylguanine and N(1)-methyladenine at position 9 of tRNAs, with HSD17B10 (MRPP2) acting as a non-catalytic subunit.
The MRPP1-MRPP2 subcomplex also serves as a tRNA maturation platform. After 5'-end cleavage by mitochondrial ribonuclease P, it enhances the efficiency of 3'-processing by ELAC2, retains the tRNA product after ELAC2 processing and presents the nascent tRNA to the CCA tRNA nucleotidyltransferase TRNT1. HSD17B10 also associates with mitochondrial DNA complexes at the nucleoids, where it helps to initiate RNA processing and ribosome assembly. The protein is found in the mitochondrial matrix and at mitochondrial nucleoids.
The HSD17B10 gene encodes a member of the short-chain dehydrogenase/reductase (SDR) superfamily, and the HGNC lists it in both that group and the mitochondrial RNase P complex group. Earlier names include hydroxyacyl-Coenzyme A dehydrogenase, type II and hydroxysteroid (17-beta) dehydrogenase 10. The protein has been implicated in the development of Alzheimer disease, and mutations in the gene cause 17beta-hydroxysteroid dehydrogenase type 10 (HSD10) deficiency, also listed as syndromic X-linked mental retardation 10. Several alternatively spliced transcript variants have been identified. Mouse and rat orthologues are both named Hsd17b10.
HSD17B10 is a subunit of mitochondrial ribonuclease P and the MRPP1-MRPP2 tRNA maturation platform, making it central to studies of mitochondrial RNA processing.
The enzyme catalyses oxidation of a wide variety of fatty acids and steroids, so it is relevant to mitochondrial dehydrogenase and lipid metabolism research.
HSD17B10 has been implicated in the development of Alzheimer disease, prompting study of its mitochondrial roles in neurodegeneration.
Mutations in the gene cause HSD10 deficiency, so the protein is studied in X-linked syndromic disorders and mitochondrial disease mechanisms.
HSD17B10 has two roles in mitochondria. It acts as a dehydrogenase that oxidises a wide variety of fatty acids and steroids, and it is a subunit of mitochondrial ribonuclease P, where it supports tRNA maturation and the methylation of tRNA position 9 as a non-catalytic subunit.
The protein was described through several activities, so it carries many aliases: ERAB, ABAD, 17b-HSD10, HADH2, MHBD, SDR5C1 and MRPP2. Its UniProt name is 3-hydroxyacyl-CoA dehydrogenase type-2. CAMR and MRXS10 are also listed, the latter reflecting syndromic X-linked mental retardation 10.
Mutations in the gene cause HSD10 deficiency, and the protein has been implicated in Alzheimer disease. Orthologues named Hsd17b10 exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other hydroxysteroid dehydrogenases from the short-chain dehydrogenase/reductase superfamily and related steroid-metabolism targets.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q99714; product specifications from Assay Genie datasheets.